Small Molecules

11 Jul 2007 Pipex Pharmaceuticals Acquires Late-Stage Oral Candidate for Dry Age-Related Macular Degeneration (AMD)
11 Jul 2007 Catalyst Pharmaceutical Partners, Inc. Initiates U.S. Phase II Clinical Trial of CPP-109 in Patients With Cocaine Dependence
11 Jul 2007 Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
11 Jul 2007 Prometic reports positive preliminary Phase Ib/II data for PBI-1402 in chemotherapy-induced anemia
11 Jul 2007 Welichem Gets Approval for Phase I Clinical Trials
10 Jul 2007 Exelon(R) Patch, the first and only skin patch for the treatment of Alzheimer's disease, receives first worldwide approval in US
10 Jul 2007 Adolor Corporation Initiates First of Three Proof of Concept Studies of Novel Delta Opioid Agonist for the Management of Pain
10 Jul 2007 Spectrum Pharmaceuticals Files Investigational New Drug Application for SPI-1620 With U.S. Food & Drug Administration
10 Jul 2007 GW and Otsuka Enter Into Global Cannabinoid Research Collaboration
10 Jul 2007 Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
10 Jul 2007 Biocryst receives special protocol assessment for pivotal trial of oral Fodosine(TM) in patients with cutaneous T-cell lymphoma
10 Jul 2007 Warner Chilcott and Paratek Pharmaceuticals Sign Collaboration Agreement for Novel, Narrow-Spectrum Agents for Acne and Rosacea
10 Jul 2007 Theravance Announces Positive Results from Phase 2 Clinical Study with Investigational Antibiotic in Patients with Complicated Skin and Skin Structure Infections
09 Jul 2007 Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
07 Jul 2007 Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
07 Jul 2007 Clavis Pharma announces initiation of malignant melanoma phase II clinical study
07 Jul 2007 Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
07 Jul 2007 Cobalis Reports Phase III Trial Results for PreHistin(TM) in Seasonal Allergic Rhinitis
06 Jul 2007 SuperGen Reports Dosing of First Patient in Phase I Trial of Novel Tyrosine Kinase Inhibitor
06 Jul 2007 ViroPharma Initiates Phase 3 Study of CAMVIA(TM) (maribavir) in Liver Transplant Patients
06 Jul 2007 Genaera Discontinues LOMUCIN(TM) in Cystic Fibrosis and Squalamine in Prostate Cancer Studies
06 Jul 2007 Depomed reacquires the rights to ProQuin(R) XR
06 Jul 2007 TMC125 Showed Significant Virologic Response at Week 24 in Treatment-Experienced HIV Patients with NNRTI Resistance in Phase 3 Trials
05 Jul 2007 Cosmo Pharmaceuticals reports positive preliminary Phase II/III data with Rifamycin MMX(TM) in Infectious Diarrhoea
04 Jul 2007 GTx Initiates Phase IIb Ostarine Clinical Trial For Cancer Cachexia

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up